Pharmaceutical Executive - Europe News
http://www.pharmexec.com/pharmexec/Europe+News/Article/list/48282
European news2013-05-23T05:02:22ZGxP Cloud — Business Enablement for Life Sciences
http://www.pharmexec.com/pharmexec/Europe+News/GxP-Cloud-mdash-Business-Enablement-for-Life-Scien/ArticleStandard/Article/detail/743615?contextCategoryId=48282&ref=25
GxP Cloud — business enablement for Life Sciences2011-10-11T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/422011/743615nullHTMLPharma Companies Contravene New ABPI Code
http://www.pharmexec.com/pharmexec/Europe+News/Pharma-Companies-Contravene-New-ABPI-Code/ArticleStandard/Article/detail/725780?contextCategoryId=48282&ref=25
Is it a coincidence that the ABPI has netted a whole shoal of conduct contraveners in the first month
its amended Code of Practice became operational?2011-06-05T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/242011/725780nullHTMLSeeing Through the Transparency Directive
http://www.pharmexec.com/pharmexec/Global/Seeing-Through-the-Transparency-Directive/ArticleStandard/Article/detail/719597?contextCategoryId=48282&ref=25
The EU is largely powerless when it comes to policies over pricing and reimbursement2011-05-01T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/192011/719597nullXMLCRM Goes Immersive
http://www.pharmexec.com/pharmexec/Europe+News/CRM-Goes-Immersive/ArticleStandard/Article/detail/714768?contextCategoryId=48282&ref=25
Software integration announced at SFE show.2011-04-04T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/152011/714768nullHTMLVacancy notice for a selection procedure open to nationals of Council of Europe member states
http://www.pharmexec.com/pharmexec/Europe+News/Vacancy-notice-for-a-selection-procedure-open-to-n/ArticleStandard/Article/detail/708766?contextCategoryId=48282&ref=25
Head of the Publications and Multimedia Department2011-02-22T05:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/092011/708766nullHTMLiPad Enables Real-Time Reps
http://www.pharmexec.com/pharmexec/Europe+News/iPad-Enables-Real-Time-Reps/ArticleStandard/Article/detail/702323?contextCategoryId=48282&ref=25
January 10, 2011.2011-01-10T05:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/032011/702323nullHTMLFinance Programme for Senior Executives
http://www.pharmexec.com/pharmexec/Europe+News/Finance-Programme-for-Senior-Executives/ArticleStandard/Article/detail/698384?contextCategoryId=48282&ref=25
The Oxford Finance Programme for Senior Executives is for directors from technical backgrounds
involved in strategic planning, and delivers the ability to identify which projects to invest in, retain or
divest.2010-12-03T05:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/492010/698384/Create_More_Value1_main.jpg
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/492010/698384nullHTMLFDA Should Improve Rate of Foreign Inspections
http://www.pharmexec.com/pharmexec/Europe/FDA-Should-Improve-Rate-of-Foreign-Inspections/ArticleStandard/Article/detail/694649?contextCategoryId=48282&ref=25
November 6, 2010.2010-11-04T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/462010/694649nullHTMLEurope Launches Early Drug Development Pilot
http://www.pharmexec.com/pharmexec/Europe+News/Europe-Launches-Early-Drug-Development-Pilot/ArticleStandard/Article/detail/694208?contextCategoryId=48282&ref=25
A European pilot initiative will test the impact of consultations with a number of stakeholders such
as patient representatives and payers on early stage drug development.2010-10-29T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/452010/694208nullHTMLEDQM vacancy notice DCEP
http://www.pharmexec.com/pharmexec/Europe+Events/EDQM-vacancy-notice-DCEP/ArticleStandard/Article/detail/692964?contextCategoryId=48282&ref=25
As part of the Certification team, you will evaluate dossiers submitted with requests for revision of
certificates of suitability to the European Pharmacopoeia and prepare draft reports; you will ensure consistency of
assessment reports for similar products and consistency of the reports with the policy of the procedure, if
necessary analysing and reporting any discrepancies.2010-10-22T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/442010/692964nullHTMLEDQM vacancy notice EPD
http://www.pharmexec.com/pharmexec/Europe+News/EDQM-vacancy-notice-EPD/ArticleStandard/Article/detail/692448?contextCategoryId=48282&ref=25
As part of a team, you will prepare meetings of European Pharmacopoeia groups of experts, contribute
to the preparation of working documents for these groups, contribute to the elaboration and revision of European
Pharmacopoeia texts and follow up meetings with a view to publication of scientific texts and
memoranda.2010-10-22T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/442010/692448nullHTMLFDA Extends Deadline for Avastin Review
http://www.pharmexec.com/pharmexec/Europe+News/FDA-Extends-Deadline-for-Avastin-Review/ArticleStandard/Article/detail/687899?contextCategoryId=48282&ref=25
September 21, 2010.2010-09-21T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/392010/687899nullHTMLRoche Plans Business Makeover
http://www.pharmexec.com/pharmexec/Europe+News/Roche-Plans-Business-Makeover/ArticleStandard/Article/detail/686186?contextCategoryId=48282&ref=25
September 08, 2010.2010-09-08T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/372010/686186nullHTMLActavis Heads into Biosimilars
http://www.pharmexec.com/pharmexec/Europe+News/Actavis-Heads-into-Biosimilars/ArticleStandard/Article/detail/686196?contextCategoryId=48282&ref=25
September 08, 2010.2010-09-08T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/372010/686196nullHTMLEU Generic Applications Down
http://www.pharmexec.com/pharmexec/Europe+News/EU-Generic-Applications-Down/ArticleStandard/Article/detail/683942?contextCategoryId=48282&ref=25
August 20, 2010.2010-08-19T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/342010/683942nullHTMLFinalists for Biotechnica Award Named
http://www.pharmexec.com/pharmexec/Europe+News/Finalists-for-Biotechnica-Award-Named/ArticleStandard/Article/detail/682978?contextCategoryId=48282&ref=25
13 August, 2010.2010-08-13T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/332010/682978nullHTMLSanofi Fights FDA Approval of Generic Lovenox
http://www.pharmexec.com/pharmexec/Europe+News/Sanofi-Fights-FDA-Approval-of-Generic-Lovenox/ArticleStandard/Article/detail/681321?contextCategoryId=48282&ref=25
August 2, 2010.2010-07-30T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/322010/681321nullHTMLServier Back in EC's Anticompetitive Behaviour Spotlight
http://www.pharmexec.com/pharmexec/Europe+News/Servier-Back-in-ECs-Anticompetitive-Behaviour-Spot/ArticleStandard/Article/detail/681440?contextCategoryId=48282&ref=25
August 01, 2010. French pharma giant accused of providing "misleading" and
"incorrect" information.2010-07-30T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/322010/681440nullHTMLDrug Safety Experts Call For New Openness
http://www.pharmexec.com/pharmexec/Europe+News/Drug-Safety-Experts-Call-For-New-Openness/ArticleStandard/Article/detail/680092?contextCategoryId=48282&ref=25
July 23, 2010.2010-07-23T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/302010/680092nullHTMLConvention Targets Counterfeiting
http://www.pharmexec.com/pharmexec/Europe+News/Convention-Targets-Counterfeiting/ArticleStandard/Article/detail/680093?contextCategoryId=48282&ref=25
July 23, 2010.2010-07-23T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/302010/680093nullHTMLEurope Earmarks €6bn for Research and Innovation
http://www.pharmexec.com/pharmexec/Europe+News/Europe-Earmarks-euro6bn-for-Research-and-Innovatio/ArticleStandard/Article/detail/680094?contextCategoryId=48282&ref=25
July 23, 2010.2010-07-23T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/302010/680094nullHTMLUK Coalition Government Unveils Radical NHS Plans
http://www.pharmexec.com/pharmexec/News+Analysis/UK-Coalition-Government-Unveils-Radical-NHS-Plans/ArticleStandard/Article/detail/678876?contextCategoryId=48282&ref=25
July 14, 2010.2010-07-14T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/292010/678876nullHTMLLilly Moves into Enzyme Replacement Therapy
http://www.pharmexec.com/pharmexec/Europe+News/Lilly-Moves-into-Enzyme-Replacement-Therapy/ArticleStandard/Article/detail/678854?contextCategoryId=48282&ref=25
July 10, 2010.2010-07-09T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/292010/678854nullHTMLActavis Appoints Generics Veteran as New CEO
http://www.pharmexec.com/pharmexec/Europe+News/Actavis-Appoints-Generics-Veteran-as-New-CEO/ArticleStandard/Article/detail/676539?contextCategoryId=48282&ref=25
June 29, 2010.2010-06-29T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/272010/676539/Actavis_main.jpg
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/272010/676539nullHTMLAlmac's Sir Allen McClay Receives Posthumous Award
http://www.pharmexec.com/pharmexec/Europe+News/Almacs-Sir-Allen-McClay-Receives-Posthumous-Award/ArticleStandard/Article/detail/675694?contextCategoryId=48282&ref=25
June 23, 2010.2010-06-23T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/262010/675694nullHTMLFirst-Call IMI Projects "Up and Running"
http://www.pharmexec.com/pharmexec/Europe+News/First-Call-IMI-Projects-Up-and-Running/ArticleStandard/Article/detail/674194?contextCategoryId=48282&ref=25
June 14, 2010.2010-06-14T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/252010/674194nullHTMLWhat Do You Think of Pharm Exec Europe?
http://www.pharmexec.com/pharmexec/Europe+News/What-Do-You-Think-of-Pharm-Exec-Europe/ArticleStandard/Article/detail/672825?contextCategoryId=48282&ref=25
Tell us and win an iPod Touch!2010-06-04T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/232010/672825nullHTMLEuropean Austerity Measures Hit Drug Prices
http://www.pharmexec.com/pharmexec/Europe+News/European-Austerity-Measures-Hit-Drug-Prices/ArticleStandard/Article/detail/672824?contextCategoryId=48282&ref=25
June 4, 2010.2010-06-04T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/232010/672824nullHTMLIrish Pharma Backs 'Innovation Island'
http://www.pharmexec.com/pharmexec/Europe+News/Irish-Pharma-Backs-Innovation-Island/ArticleStandard/Article/detail/671189?contextCategoryId=48282&ref=25
May 24, 2010.2010-05-24T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/222010/671189nullHTMLPatent Cliff Pushes Pharma to the Brink
http://www.pharmexec.com/pharmexec/Europe+News/Patent-Cliff-Pushes-Pharma-to-the-Brink/ArticleStandard/Article/detail/671187?contextCategoryId=48282&ref=25
May 24, 2010.2010-05-20T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/222010/671187nullHTMLRecord Year for Doctors Online
http://www.pharmexec.com/pharmexec/Europe+News/Record-Year-for-Doctors-Online/ArticleStandard/Article/detail/669094?contextCategoryId=48282&ref=25
May 7, 2010.2010-05-07T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/192010/669094nullHTMLERBI and London Biotechnology Network to Merge
http://www.pharmexec.com/pharmexec/Europe+News/ERBI-and-London-Biotechnology-Network-to-Merge/ArticleStandard/Article/detail/669093?contextCategoryId=48282&ref=25
May 7, 2010.2010-05-07T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/192010/669093nullHTMLThe Ageing Society – How Will We Pay for It?
http://www.pharmexec.com/pharmexec/Europe/The-Ageing-Society-ndash-How-Will-We-Pay-for-It/ArticleStandard/Article/detail/667551?contextCategoryId=48282&ref=25
An exclusive report for Pharm Exec Europe by IMS Health.2010-04-30T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/182010/667551nullHTMLEMA to Improve Benefit-Risk Assessments
http://www.pharmexec.com/pharmexec/Europe/EMA-to-Improve-Benefit-Risk-Assessments/ArticleStandard/Article/detail/667545?contextCategoryId=48282&ref=25
April 29, 2010.2010-04-29T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/182010/667545nullHTMLEuropean Medicines Agency Praised in Evaluation
http://www.pharmexec.com/pharmexec/Europe+News/European-Medicines-Agency-Praised-in-Evaluation/ArticleStandard/Article/detail/666348?contextCategoryId=48282&ref=25
April 21, 2010.2010-04-23T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/172010/666348nullHTMLBayer Says 'Bye to Arthur Higgins
http://www.pharmexec.com/pharmexec/Europe+News/Bayer-Says-Bye-to-Arthur-Higgins/ArticleStandard/Article/detail/666350?contextCategoryId=48282&ref=25
April 22, 2010.2010-04-22T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/172010/666350nullHTMLRegenerative Medicines Hold "Promise of Cures"
http://www.pharmexec.com/pharmexec/Europe+News/Regenerative-Medicines-Hold-Promise-of-Cures/ArticleStandard/Article/detail/666349?contextCategoryId=48282&ref=25
April 21, 2010.2010-04-16T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/172010/666349nullHTMLUK Election Brings Anti-Cancer Treatment to the Fore
http://www.pharmexec.com/pharmexec/Europe/UK-Election-Brings-Anti-Cancer-Treatment-to-the-Fo/ArticleStandard/Article/detail/665020?contextCategoryId=48282&ref=25
April 13, 2010.2010-04-13T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/162010/665020nullHTMLThe Changing Face of European Regulatory Affairs
http://www.pharmexec.com/pharmexec/Europe/The-Changing-Face-of-European-Regulatory-Affairs/ArticleStandard/Article/detail/663632?contextCategoryId=48282&ref=25
In 1995, pharmaceutical regulation in Europe underwent a dramatic change with the emergence of the
European Medicines Agency. The agency's 15-year history has been eventful, with it having to adapt to a changing
regulatory landscape and new expectations from those relying on it for guidance.2010-04-01T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/142010/663632nullXMLUK to Appoint First Minister for Life Sciences
http://www.pharmexec.com/pharmexec/Europe+News/UK-to-Appoint-First-Minister-for-Life-Sciences/ArticleStandard/Article/detail/662947?contextCategoryId=48282&ref=25
March 25, 2010.2010-03-26T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/132010/662947nullHTMLHungary to Expand Clinical Trial Offering
http://www.pharmexec.com/pharmexec/Europe+News/Hungary-to-Expand-Clinical-Trial-Offering/ArticleStandard/Article/detail/662398?contextCategoryId=48282&ref=25
March 24, 2010.2010-03-24T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/132010/662398nullHTML10 New Countries Join 'Pharmerging Markets'
http://www.pharmexec.com/pharmexec/Europe+News/10-New-Countries-Join-Pharmerging-Markets/ArticleStandard/Article/detail/661601?contextCategoryId=48282&ref=25
March 17, 2010.2010-03-17T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/122010/661601nullHTMLNew Insights Into Open Innovation
http://www.pharmexec.com/pharmexec/Europe/New-Insights-Into-Open-innovation/ArticleStandard/Article/detail/660965?contextCategoryId=48282&ref=25
Open innovation is sometimes chaotic and often difficult to measure, but getting it right can give
firms a real edge now and in the future.2010-03-11T05:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/112010/660965nullHTMLReport Predicts Major Slowdown for Big Pharma
http://www.pharmexec.com/pharmexec/Europe+News/Report-Predicts-Major-Slowdown-for-Big-Pharma/ArticleStandard/Article/detail/659971?contextCategoryId=48282&ref=25
4 March, 20102010-03-04T05:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/102010/659971nullHTMLPositive Outlook for UK Biotech Jobs
http://www.pharmexec.com/pharmexec/Europe+News/Positive-Outlook-for-UK-Biotech-Jobs/ArticleStandard/Article/detail/659067?contextCategoryId=48282&ref=25
February 26, 2010.2010-02-25T05:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/092010/659067nullHTMLGenzyme Expands UK Site
http://www.pharmexec.com/pharmexec/Europe+News/Genzyme-Expands-UK-Site/ArticleStandard/Article/detail/657776?contextCategoryId=48282&ref=25
February 18, 2010.2010-02-18T05:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/082010/657776nullHTMLFormer Schering-Plough CEO Speaks Out on M&As
http://www.pharmexec.com/pharmexec/Europe+News/Former-Schering-Plough-CEO-Speaks-Out-on-MampAs/ArticleStandard/Article/detail/657354?contextCategoryId=48282&ref=25
February 16, 2010.2010-02-16T05:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/082010/657354nullHTMLEurope Reveals Generic Dominance
http://www.pharmexec.com/pharmexec/Europe+News/Europe-Reveals-Generic-Dominance/ArticleStandard/Article/detail/656356?contextCategoryId=48282&ref=25
February 10, 2010.2010-02-10T05:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/072010/656356nullHTMLActavis Ray of Hope for Beleaguered Iceland
http://www.pharmexec.com/pharmexec/Europe+News/Actavis-Ray-of-Hope-for-Beleaguered-Iceland/ArticleStandard/Article/detail/655842?contextCategoryId=48282&ref=25
8 February, 2010.2010-02-08T05:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/072010/655842nullHTMLEmergency Contraception Drug Breakthrough
http://www.pharmexec.com/pharmexec/Europe+News/Emergency-Contraception-Drug-Breakthrough/ArticleStandard/Article/detail/653966?contextCategoryId=48282&ref=25
January 29, 2010.2010-01-29T05:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/052010/653966nullHTMLEC to Scrutinize Patent Settlements
http://www.pharmexec.com/pharmexec/Europe+News/EC-to-Scrutinize-Patent-Settlements/ArticleStandard/Article/detail/651790?contextCategoryId=48282&ref=25
January 13, 2010.2010-01-13T05:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/032010/651790nullHTMLGSKs Andrew Witty New EFPIA President
http://www.pharmexec.com/pharmexec/Europe+News/GSKs-Andrew-Witty-New-EFPIA-President/ArticleStandard/Article/detail/650400?contextCategoryId=48282&ref=25
January 06, 2010.2010-01-06T05:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/022010/650400nullHTMLNovartis Eyes Full Takeover of Alcon
http://www.pharmexec.com/pharmexec/Europe+News/Novartis-Eyes-Full-Takeover-of-Alcon/ArticleStandard/Article/detail/650048?contextCategoryId=48282&ref=25
January 04. 2010.2010-01-04T05:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/022010/650048nullHTMLAcquisition boosts Sanofi's US consumer healthcare profile
http://www.pharmexec.com/pharmexec/Europe+News/Acquisition-boosts-Sanofis-consumer-healthcare-pro/ArticleStandard/Article/detail/649490?contextCategoryId=48282&ref=25
December 23, 2009.2009-12-23T05:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/522009/649490nullHTMLCorrupt Practices Cost Healthcare $23 Billion
http://www.pharmexec.com/pharmexec/Europe+News/Corrupt-Practices-Cost-Healthcare-23-Billion/ArticleStandard/Article/detail/649111?contextCategoryId=48282&ref=25
December 18, 2009.2009-12-18T05:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/512009/649111nullHTMLM&As Set to Dominate Pharma Until 2014
http://www.pharmexec.com/pharmexec/Europe+News/MampAs-Set-to-Dominate-Pharma-Until-2014/ArticleStandard/Article/detail/648955?contextCategoryId=48282&ref=25
December 17, 2009.2009-12-17T05:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/512009/648955nullHTMLPersonalized Medicine Market To Grow 11% Annually
http://www.pharmexec.com/pharmexec/Europe+News/Personalized-Medicine-Market-To-Grow-11-Annually/ArticleStandard/Article/detail/648493?contextCategoryId=48282&ref=25
December 15, 2009.2009-12-15T05:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/512009/648493nullHTMLScottish Life Science Sector Receives Euro 26 Million Boost
http://www.pharmexec.com/pharmexec/Europe+News/Scottish-Life-Science-Sector-Receives-Euro-26-Mill/ArticleStandard/Article/detail/647663?contextCategoryId=48282&ref=25
11 December.2009-12-10T05:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/502009/647663nullHTML2010 Products and Therapy Areas to Watch
http://www.pharmexec.com/pharmexec/Europe+Features/2010-Products-and-Therapy-Areas-to-Watch/ArticleStandard/Article/detail/645698?contextCategoryId=48282&ref=25
Thomson Reuters' global pharma forecast for next year.2009-12-04T05:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/492009/645698/thomson2_main.jpg
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/492009/645698nullHTMLEuropean Pharma Finally Becomes a Health Matter
http://www.pharmexec.com/pharmexec/Europe+News/European-Pharma-Finally-Becomes-a-Health-Matter/ArticleStandard/Article/detail/644843?contextCategoryId=48282&ref=25
December 012009-12-01T05:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/492009/644843nullHTMLThe Evolving Drug Safety Landscape: Implications for Pharma
http://www.pharmexec.com/pharmexec/Europe+News/The-Evolving-Drug-Safety-Landscape-Implications-fo/ArticleStandard/Article/detail/644814?contextCategoryId=48282&ref=25
01 December2009-12-01T05:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/492009/644814nullHTMLBio-Entrepreneur School Welcomes New Applications
http://www.pharmexec.com/pharmexec/Europe+News/Bio-Entrepreneur-School-Welcomes-New-Applications/ArticleStandard/Article/detail/641866?contextCategoryId=48282&ref=25
16 November 2009.2009-11-16T05:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/472009/641866nullHTMLNovo Nordisk Reports 30% Increased Operating Profit
http://www.pharmexec.com/pharmexec/Europe+News/Novo-Nordisk-Reports-30-Increased-Operating-Profit/ArticleStandard/Article/detail/638252?contextCategoryId=48282&ref=25
02 November2009-11-02T05:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/452009/638252nullHTML10,000 UK Cancer Deaths Could be Avoided
http://www.pharmexec.com/pharmexec/Europe+News/10000-UK-Cancer-Deaths-Could-be-Avoided/ArticleStandard/Article/detail/637078?contextCategoryId=48282&ref=25
28 October2009-10-28T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/442009/637078nullHTMLCROs United
http://www.pharmexec.com/pharmexec/Europe+News/CROs-United/ArticleStandard/Article/detail/636759?contextCategoryId=48282&ref=25
US-based CRO, Health Decisions, hopes to raise the efficacy standards for complex studies and help
companies get products to market faster by establishing an international network of CROs.2009-10-27T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/442009/636759nullHTMLUK's NICE Rejects GSK Breast Cancer Treatment
http://www.pharmexec.com/pharmexec/Europe+News/UKs-NICE-Rejects-GSK-Breast-Cancer-Treatment/ArticleStandard/Article/detail/635531?contextCategoryId=48282&ref=25
21 October2009-10-21T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/432009/635531nullHTMLSwitzerland's Medicines for Malaria Receives Gates Foundation Award
http://www.pharmexec.com/pharmexec/Europe+News/Switzerlands-Medicines-for-Malaria-Receives-Gates-/ArticleStandard/Article/detail/634872?contextCategoryId=48282&ref=25
19 October2009-10-19T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/432009/634872nullHTMLEconomist Award for Bioscience Innovation Announced
http://www.pharmexec.com/pharmexec/Europe+News/Economist-Award-for-Bioscience-Announced/ArticleStandard/Article/detail/633542?contextCategoryId=48282&ref=25
13 October2009-10-13T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/422009/633542nullHTMLRA Treatment Uneven Across Europe
http://www.pharmexec.com/pharmexec/Europe+News/RA-Treatment-Uneven-Across-Europe/ArticleStandard/Article/detail/633347?contextCategoryId=48282&ref=25
12 October2009-10-12T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/422009/633347nullHTMLSandoz Launches First Biosimilar in Japan
http://www.pharmexec.com/pharmexec/Europe+News/Sandoz-Launches-First-Biosimilar-in-Japan/ArticleStandard/Article/detail/631745?contextCategoryId=48282&ref=25
06 October2009-10-06T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/412009/631745nullHTMLTakeda Targets Most Promising Markets
http://www.pharmexec.com/pharmexec/Europe+News/Takeda-Targets-Most-Promising-Markets/ArticleStandard/Article/detail/631226?contextCategoryId=48282&ref=25
05 October2009-10-05T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/412009/631226nullHTMLBiotech "Uneven" in New EU Member States
http://www.pharmexec.com/pharmexec/Europe+News/Biotech-Uneven-in-EU-Member-States/ArticleStandard/Article/detail/631115?contextCategoryId=48282&ref=25
02 October2009-10-02T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/402009/631115nullHTMLSanofi Acquires Fovea in 370M Deal
http://www.pharmexec.com/pharmexec/Europe+News/Sanofi-Acquires-Fovea-in-370M-Deal/ArticleStandard/Article/detail/630595?contextCategoryId=48282&ref=25
01 October 20092009-10-01T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/402009/630595nullHTMLAlmac Plans 500 New Jobs for Northern Ireland
http://www.pharmexec.com/pharmexec/Europe+News/Almac-Plans-500-New-Jobs-for-Northern-Ireland/ArticleStandard/Article/detail/630142?contextCategoryId=48282&ref=25
30 September 20092009-09-30T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/402009/630142nullHTMLIMI Announces Next Topics for Research
http://www.pharmexec.com/pharmexec/Europe+News/IMI-Announces-Next-Topics-for-Research/ArticleStandard/Article/detail/626551?contextCategoryId=48282&ref=25
15 September 20092009-09-15T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/382009/626551nullHTMLAstraZeneca wins over UK doctors
http://www.pharmexec.com/pharmexec/Europe+News/AstraZeneca-wins-over-UK-doctors/ArticleStandard/Article/detail/625465?contextCategoryId=48282&ref=25
10 September 20092009-09-10T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/372009/625465nullHTMLAlgeta & Bayer in cancer drug deal
http://www.pharmexec.com/pharmexec/Europe+News/Algeta-amp-Bayer-in-cancer-drug-deal/ArticleStandard/Article/detail/623829?contextCategoryId=48282&ref=25
3rd September 20092009-09-03T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/362009/623829nullHTMLGlobal Cancer Cases to Grow by 30 Per Cent
http://www.pharmexec.com/pharmexec/Europe+News/Global-Cancer-Cases-to-Grow-by-30-Per-Cent/ArticleStandard/Article/detail/623601?contextCategoryId=48282&ref=25
2 September 20092009-09-02T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/362009/623601nullHTMLGuiding Your Drug Name to Approval
http://www.pharmexec.com/pharmexec/Europe/Guiding-Your-Drug-Name-to-Approval/ArticleStandard/Article/detail/617169?contextCategoryId=48282&ref=25
06 August 20092009-08-24T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/322009/617169nullHTMLPfizer to develop clinical trial website
http://www.pharmexec.com/pharmexec/Europe+News/Pfizer-to-develop-clinical-trial-website/ArticleStandard/Article/detail/620739?contextCategoryId=48282&ref=25
21 August 20092009-08-21T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/342009/620739nullHTMLObama Advisor to Open Swedish Life Sciences Summit
http://www.pharmexec.com/pharmexec/Europe/Obama-Advisor-to-Open-Swedish-Life-Sciences-Summit/ArticleStandard/Article/detail/619614?contextCategoryId=48282&ref=25
18 August 20092009-08-18T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/342009/619614nullHTMLIs Tamiflu Suitable for Young Children?
http://www.pharmexec.com/pharmexec/Europe+News/Is-Tamiflu-Suitable-for-Young-Children/ArticleStandard/Article/detail/617908?contextCategoryId=48282&ref=25
11 August2009-08-11T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/332009/617908nullHTMLPfizer settles Nigerian Trovan case
http://www.pharmexec.com/pharmexec/Europe/Pfizer-settles-Nigerian-Trovan-case/ArticleStandard/Article/detail/615966?contextCategoryId=48282&ref=25
3 August 20092009-08-03T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/322009/615966nullHTMLA busy time for Sanofi
http://www.pharmexec.com/pharmexec/Europe/A-busy-time-for-Sanofi/ArticleStandard/Article/detail/615488?contextCategoryId=48282&ref=25
31 July 20092009-07-31T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/312009/615488nullHTMLFlu Vaccines Fast-Tracked in EU
http://www.pharmexec.com/pharmexec/Europe+News/Flu-Vaccines-Fast-Tracked-in-EU/ArticleStandard/Article/detail/615230?contextCategoryId=48282&ref=25
30 July 20092009-07-30T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/312009/615230nullHTMLEuropean Approval for Pfizer-Wyeth Deal
http://www.pharmexec.com/pharmexec/Europe+News/European-Approval-for-Pfizer-Wyeth-Deal/ArticleStandard/Article/detail/612293?contextCategoryId=48282&ref=25
20 July 20092009-07-20T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/302009/612293nullHTMLUK 'Life Sciences Blueprint' Welcomed
http://www.pharmexec.com/pharmexec/Europe+News/UK-Life-Sciences-Blueprint-Welcomed/ArticleStandard/Article/detail/611708?contextCategoryId=48282&ref=25
16 July 20092009-07-16T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/292009/611708nullHTMLServier Singled Out for New EU Antitrust Investigation
http://www.pharmexec.com/pharmexec/Europe/Servier-Singled-Out-for-New-EU-Antitrust-Investiga/ArticleStandard/Article/detail/609542?contextCategoryId=48282&ref=25
08 July 20092009-07-08T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/282009/609542nullHTMLMerck signs discovery deal with Xenon
http://www.pharmexec.com/pharmexec/Europe+News/Merck-signs-discovery-deal-with-Xenon/ArticleStandard/Article/detail/603134?contextCategoryId=48282&ref=25
12 June 20092009-06-12T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/242009/603134nullHTMLA Cautionary Tale for Executives
http://www.pharmexec.com/pharmexec/Europe/A-Cautionary-Tale-for-Executives/ArticleStandard/Article/detail/602420?contextCategoryId=48282&ref=25
9 June 20092009-06-09T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/242009/602420nullHTMLPharmaceutical Execs Embrace the Web
http://www.pharmexec.com/pharmexec/Europe/Pharmaceutical-Execs-Embrace-the-Web/ArticleStandard/Article/detail/601618?contextCategoryId=48282&ref=25
4 June 20092009-06-04T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/232009/601618nullHTMLIMS revises predicted global pharma growth rate
http://www.pharmexec.com/pharmexec/Europe+News/IMS-revises-predicted-global-pharma-growth-rate/ArticleStandard/Article/detail/601641?contextCategoryId=48282&ref=25
New prediction reflects incremental pressure from economic crisis.2009-06-04T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/232009/601641nullHTMLPfizer completes European debt offering
http://www.pharmexec.com/pharmexec/Europe/Pfizer-completes-European-debt-offering/ArticleStandard/Article/detail/601617?contextCategoryId=48282&ref=25
4 June 20092009-06-04T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/232009/601617nullHTMLAstraZeneca and Merck form collaboration
http://www.pharmexec.com/pharmexec/Europe/AstraZeneca-and-Merck-form-collaboration/ArticleStandard/Article/detail/600890?contextCategoryId=48282&ref=25
1 June 20092009-06-01T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/232009/600890nullHTMLElan in talks to sell stake to Bristol
http://www.pharmexec.com/pharmexec/Europe/Elan-in-talks-to-sell-stake-to-Bristol/ArticleStandard/Article/detail/600889?contextCategoryId=48282&ref=25
1 June 20092009-06-01T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/232009/600889nullHTMLGW Pharma seeks approval for cannabis-based drug
http://www.pharmexec.com/pharmexec/Europe+News/GW-Pharma-seeks-approval-for-cannabis-based-drug/ArticleStandard/Article/detail/600049?contextCategoryId=48282&ref=25
28 May 20092009-05-28T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/222009/600049nullHTMLRanbaxy chief steps down
http://www.pharmexec.com/pharmexec/Europe+News/Ranbaxy-chief-steps-down/ArticleStandard/Article/detail/600047?contextCategoryId=48282&ref=25
1 June 20092009-05-28T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/222009/600047nullHTMLGSK to donate 50 million pandemic vaccines
http://www.pharmexec.com/pharmexec/Europe+News/GSK-to-donate-50-million-pandemic-vaccines/ArticleStandard/Article/detail/600050?contextCategoryId=48282&ref=25
21 May 20092009-05-28T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/222009/600050nullHTMLUK charity plugs drug R&D gap
http://www.pharmexec.com/pharmexec/Europe+News/UK-charity-plugs-drug-RampD-gap/ArticleStandard/Article/detail/600052?contextCategoryId=48282&ref=25
Cancer Research Technology, a British cancer charity, is to fund clinical trials of a drug owned by
GlaxoSmithKline (GSK), in a groundbreaking programme to develop promising experimental medicines that are neglected
due to limited corporate funding.2009-05-28T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/222009/600052nullHTMLNovartis buys Ebewe injectables unit
http://www.pharmexec.com/pharmexec/Europe+News/Novartis-buys-Ebewe-injectables-unit/ArticleStandard/Article/detail/600051?contextCategoryId=48282&ref=25
28 May 20092009-05-28T04:00:00Z
http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/222009/600051nullHTML